Aquestive Therapeutics, Inc. (AQST)
6.24
+0.14
(+2.30%)
USD |
NASDAQ |
Dec 10, 16:00
6.22
-0.02
(-0.32%)
After-Hours: 17:00
Aquestive Therapeutics Profit Margin (Quarterly): -120.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 28.31% |
| Eli Lilly & Co. | 31.72% |
| Madrigal Pharmaceuticals, Inc. | -39.75% |
| TransCode Therapeutics, Inc. | -- |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -60.42% |
| Return on Invested Capital | -91.28% |
| Gross Profit Margin (Quarterly) | 64.82% |
| Operating Margin (Quarterly) | -89.63% |
| Return on Net Operating Assets | -285.8% |